care & love
For any rehabilitation department considering robotic gait therapy, the question of how sessions get paid is usually the first one managers want answered. Robotic exoskeleton training for the lower limbs no longer lives on the margins of rehabilitation finance — national health systems, private insurers and facility budgets have all begun to treat it as a mainstream treatment option. But "covered" rarely means "unconditionally paid." The reimbursement path depends on where the therapy happens, who is treating the patient, and how the session is documented. Below we walk through the realistic insurance reimbursement options for walking-robot therapy sessions.
Walking-robot therapy, often described as robot-assisted gait training, uses a powered lower-limb exoskeleton to carry the patient through a natural stepping pattern while a therapist supervises. It is prescribed most often after stroke, spinal cord injury, traumatic brain injury, orthopedic surgery and for children with certain motor disorders. The clinical argument is well established: high-repetition, consistent stepping improves walking ability, corrects abnormal gait and helps reduce secondary complications such as pain and spasticity. What makes it distinct in a budget conversation is that the equipment cost is upfront and substantial, while the per-session clinical cost can be kept reasonable — which is exactly why reimbursement behavior matters so much.
Reimbursement is not one single door. It splits roughly into two tracks. In inpatient rehabilitation, walking-robot sessions are usually delivered by hospital-based physical therapists as part of an episode of care, and they sit inside the facility's bundled therapy billing. This is the setting where coverage has grown fastest, because it is tied to a physician-prescribed plan for a defined diagnosis. In outpatient or community-based clinics, sessions are billed independently and payers tend to be stricter — they want proof of medical necessity and usually ask the patient to complete a trial of conventional physical therapy first.
Understanding which track applies to your patients is the shortcut to avoiding denials. A clinic that knows whether its claims will be routed through the hospital bundle or through an individual outpatient code can shape its documentation, its equipment and its staffing model around that reality.
Government programs. Public programs have led the way in recognizing exoskeleton therapy. The United States Veterans Administration was among the first to put a formal policy in place, supporting eligible veterans with standing and walking training in their homes and communities. More recently, from the start of 2024, Medicare began covering personal exoskeletons as a brace category for medically eligible beneficiaries — a signal that government payers now accept these devices as durable medical tools rather than experimental technology. For facilities, this shifts the practical question from "will it ever be paid?" to "does this specific patient meet the criteria?"
Private insurance and managed care. Commercial plans generally treat robotic rehabilitation on a case-by-case basis. The deciding factors are almost always the same: a documented diagnosis that impairs gait, a goal to improve mobility, a prescription from a qualified clinician, and — for most plans — evidence that conservative therapy was tried first. Prior authorization is common, so submitting the medical record alongside the claim in the first round saves weeks of back-and-forth.
Workers' compensation. Because many walking-robot patients are recovering from work-related injury, workers' compensation can be a realistic channel, especially for orthopedic and spinal cases. These claims are governed by state or regional rules, but when gait impairment is clearly linked to a workplace injury, coverage is often more attainable than a typical commercial plan.
Self-pay and packaged pricing. For clinics and home-care providers that want to offer the therapy to patients whose coverage is uncertain, self-pay packages are the most predictable option. By folding equipment amortization and therapist time into a per-session or per-week price, the facility controls its own revenue and can offer treatment to a much wider population. Many institutions start with self-pay while they build the documentation history needed to win later reimbursements.
Across almost all channels, the same checklist recurs. Patients typically need a diagnosis that impairs gait — stroke, spinal cord injury, cerebral palsy or similar — and a documented goal to improve mobility. Most insurers require a trial of traditional therapy first, though exceptions exist for severe cases. Every session must be documented by a licensed professional, with progress notes tied to measurable functional goals. And because policies change frequently, the safest habit is to verify real-time eligibility at the start of every new patient pathway rather than assuming last year's rule still applies.
None of this financing works if the per-session cost is too high to price competitively. This is where equipment choice meets reimbursement strategy. A facility that invests in a robotic gait trainer with a realistic total cost of ownership — efficient donning, low ongoing maintenance and training support — can price its sessions attractively while still covering its investment. This is precisely the gap that Mona Care's walking-robot range addresses for rehabilitation departments, neurology and neurosurgery units, and intensive care settings.
Mona Care offers a family of lower limb exoskeleton robot systems designed for professional medical use. The Bear Adult, built for adults with lower-limb motor dysfunction, simulates natural human gait through biomechanical modeling and delivers repetitive high-frequency walking training, with continuous torque output to support multiple functional training modes. For pediatric programs, the Rabbit Kid offers a safe, comfortable human-machine interaction and multiple training modes for children, and has already seen use in Hong Kong schools and a children's hospital. The Gait Assist adds multi-sensor motion-intention recognition, personalized parameter adjustment and training-data export — useful for building exactly the kind of measurable documentation that insurers and researchers want to see. All three carry IEC 60601 safety testing, which matters when a payer or an accreditation body asks about reliability.
There is no single answer that fits every clinic, because reimbursement is shaped by geography, payer policy and the patient's diagnosis. The practical pattern, though, is consistent. Run an eligibility check before the therapy starts. Route the claim through the correct channel — hospital bundle, government program, private plan, workers' compensation or self-pay. Prepare the medical record and prior-authorization documents in advance. And build your per-session economics on equipment that keeps the service affordable without sacrificing safety. Walking-robot therapy is increasingly a billable, sustainable service line; the programs that treat reimbursement as part of their planning rather than an afterthought are the ones that make it work.
If your department is evaluating how to introduce or expand robot-assisted gait training, Mona Care's team can help you understand the options and match the right system to your patient population and budget. Contact them through the Mona Care contact page for a conversation about equipment, training and cost planning.